PR Newswire·May 7, 2026, 3:00 AM ET

Yatsen's $100 Million R&D Investment Wins Consumer Trust and Market Share

Chinese domestic cosmetics brands captured nearly 60% of the global beauty market in 2026, up from 43% in 2015.
Market growth is driven by a shift from price-based competition to technology-driven excellence & scientific innovation.
Yatsen Group invested approximately $100 million (RMB 700 million) in R&D since 2020 to support this transformation.
Consumer preferences have evolved to prioritize proven efficacy, safety, scientific credibility, & cultural identity over low cost.
Yatsen employs a "1-3-4-6-20" global innovation strategy featuring three research centers in Shanghai, Guangzhou, & Toulouse.
Over half of Yatsen's R&D team holds master's or PhD degrees, & the company maintains six joint laboratories with 20+ collaborative programs.
Key brand initiatives include Perfect Diary's "makeup skinification," DR.WU's clinic-grade renewal, Galénic's cellular anti-aging, & Eve Lom's neuroscience-based emotional skincare.
Perfect Diary has expanded into Southeast Asia & Japan, ranking among the top three loose powders on major e-commerce platforms in those regions.
Frost & Sullivan data identifies Perfect Diary Biolip Essence Lipstick as the top-selling lipstick SKU by a Chinese brand worldwide.
Industry analysts note a transition from supply-chain-driven product globalization to innovation-led brand globalization.
Yatsen Holding Limited (NYSE: YSG), founded in 2016, leverages agility & robust R&D to serve mass, prestige, & clinical market segments.